Overview
Ischemic heart disease is prevalent in the United States, with more than 1,100,000 people suffering a myocardial infarction each year and more than 16 million diagnosed with angina. In addition to being widespread, ischemic heart disease accounts for considerable morbidity and mortality. As the leading single cause of death in the United States, it is responsible for 1 of every 4.8 deaths.
The treatment of ischemic heart disease focuses on two areas: 1) prevention of myocardial infarction and death, and 2) reduction of symptoms and occurrence of ischemia to improve quality of life. Although all University Cardiology Associates treat patients with ischemic heart disease, selected members of our group focus on refining current therapy and defining the valve for novel treatment options.
Members of our invasive cardiology group participate in the development of new therapeutic options for percutaneous coronary interventions such as drug eluting stents. Members of the preventive cardiology group and vascular biology group are actively engaged in defining mechanisms responsible for myocardial infarction as well as more effective methods to prevent these events.
The cardiac rehabilitation unit seeks to improve recovery after cardiac events. The cardiac imaging group focuses on defining the extent and functional implications of ischemic heart disease. A particular strength of our group is in defining the role and treatment of thrombosis in ischemic heart disease.
